You are here: Industry Insights > COVID-19 vaccine

News List

Serbia gets shipment of AstraZeneca COVID-19 vaccine made in India expresspharma
February 22, 2021
A shipment of 150,000 COVID-19 vaccines developed by AstraZeneca and Oxford University arrived at Belgrade airport on Sunday, making Serbia the first country in the Western Balkan region to receive supplies of the shot.
World Bank striving for standard vaccine contracts, more data from vaccine producers expresspharma
February 22, 2021
World Bank President David Malpass informed he expected the bank’s board to have approved $1.6 billion in vaccine funding for 12 countries by the end of March, with 30 more to follow shortly thereafter.
Serum Institute of India says prioritising domestic vaccine needs expresspharma
February 22, 2021
Many low-and middle-income countries, ranging from Bangladesh to Brazil, are depending on SII’s AstraZeneca vaccine, branded COVISHIELD.
China approves clinical trials for 16 indigenous COVID-19 vaccines expresspharma
February 22, 2021
China has already given conditional approval to two inactivated COVID-19 vaccines made by state-owned developers -- Sinopharm and Sinovac Biotech.
Pfizer and BioNTech begin Covid-19 vaccine trial in pregnant women pharmaceutical-technology
February 20, 2021
Pfizer and BioNTech have dosed the first participants in a global Phase II / III study of their vaccine in preventing Covid-19 in healthy pregnant women aged 18 and above.
UK to pledge to share surplus Covid-19 vaccines at G7 meeting pharmaceutical-technology
February 20, 2021
UK Prime Minister Boris Johnson will pledge to donate surplus Covid-19 vaccines to poorer countries at a virtual G7 meeting.
Bharat Biotech seeks approval for COVID-19 vaccine in over 40 countries expresspharma
February 20, 2021
Pricing of COVAXIN for international markets will be based upon supply timelines, purchase commitments and procurement volumes, informed the company.
CureVac’s COVID-19 vaccine begins rolling review with EMA pharmatimes
February 19, 2021
German biopharmaceutical company CureVac has announced the initiation of a rolling review with the European Medicines Agency (EMA) for its mRNA-based COVID-19 vaccine, CVnCoV.
FDA clears Altimmune’s IND application for Covid-19 vaccine candidate trial pharmaceutical-technology
February 19, 2021
The US Food and Drug Administration (FDA) has cleared Altimmune’s Investigational New Drug (IND) application for its Phase I clinical trial of an intranasal Covid-19 vaccine candidate, AdCOVID.
Janssen-Cilag seeks EMA authorisation for Covid-19 vaccine candidate pharmaceutical-technology
February 19, 2021
Johnson & Johnson’s (J&J) Janssen-Cilag International has announced it applied to the European Medicines Agency (EMA) to obtain authorisation for its Covid-19 vaccine candidate.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page